Skip to main content

Coherus Oncology, Inc.

CHRS
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001512762

No open-market purchases or sales by Coherus Oncology, Inc. insiders were filed in the last 90 days; 146 institutions reported holding it in 13F filings for Q2 2026, worth $98.5M in total; no superinvestor holds it.

Q3 2022 vs. Q2 2022

How the institutions holding Coherus Oncology, Inc. changed between Q2 2022 and Q3 2022.

All holders in Q3 2022All holders in Q2 2022

13F holders of CHRS: Q2 2022 compared with Q3 2022
MeasureQ2 2022Q3 2022Change
Holders176174−2
Shares78.9M77.4M−1.54M (−1.9%)
Value$572.0M$743.4M+$171.5M (+30.0%)

New holders (21)

Institutions that held Coherus Oncology, Inc. at the end of Q3 2022 but not at the end of Q2 2022.

Institutions new to CHRS in Q3 2022
InstitutionSharesValue% of portfolio
Kennedy Capital Management, Inc.202,536$1.95M0.06%
Emerald Mutual Fund Advisers Trust191,245$1.84M0.12%
Citadel Advisors LLC189,562$1.82M0.00%
ExodusPoint Capital Management, LP143,601$1.38M0.02%
HRT Financial LP99,287$954.0K0.01%
Squarepoint Ops LLC72,511$697.0K0.01%
AlphaCentric Advisors LLC53,000$509.0K0.52%
Mesirow Financial Investment Management, Inc.31,986$307.0K1.46%
Marshall Wace, LLP30,534$294.0K0.00%
Natixis24,500$235.0K0.00%
Virginia Retirement Systems Et Al21,700$208.5K0.00%
Teacher Retirement System of Texas20,392$196.0K0.00%
Teachers Retirement System of the State of Kentucky18,465$177.0K0.00%
Verition Fund Management LLC10,671$103.0K0.00%
Parallax Volatility Advisers, L.P.7,298$70.0K0.00%
Dark Forest Capital Management LP1,129$11.0K0.00%
China Universal Asset Management Co., Ltd.728$7.00K0.00%
Allworth Financial LP75$1.00K0.00%
Absolute Capital Management, LLC27$2520.00%
Farmers & Merchants Investments Inc40$00.00%
Lindbrook Capital, LLC37$00.00%

Sold out (23)

Institutions that held Coherus Oncology, Inc. at the end of Q2 2022 and filed for Q3 2022 without it.